Source: Health Products Regulatory Authority (IE) Revision Year: 2019 Publisher: Elara Pharmaservices Europe Limited, 239 Blanchardstown Corporate Park, Ballycoolin, Dublin, Dublin, D15KV21, Ireland
Taurolin 2% w/v solution for intraperitoneal lavage after dilution or solution for instillation.
| Pharmaceutical Form |
|---|
|
Solution for intraperitoneal lavage after dilution or solution for instillation. Clear, colourless to very faintly reddish solution with a pH of 7.0 to 7.6. |
Active ingredient: Taurolidine 2% w/v, 2.0 g/100 ml.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Taurolidine |
Taurolidine inhibits the formation of postoperative peritoneal adhesions, and in vitro has been shown to reduce the adherence of micro-organisms to mucosal epithelium. The chemical mode of action of taurolidine via its reactive methylol groups confers greater potency in vivo than indicated by in vitro MIC values, and also appears to preclude susceptibility to resistance mechanisms. |
| List of Excipients |
|---|
|
Povidone |
Clear, Type II Ph.Eur. glass bottles (100ml and 250ml) with rubber closures and aluminium snap caps.
Elara Pharmaservices Europe Limited, 239 Blanchardstown Corporate Park, Ballycoolin, Dublin, Dublin, D15KV21, Ireland
PA22637/005/001
Date of authorisation: 13 March 1987
Date of last renewal: 13 March 2007
| Drug | Countries | |
|---|---|---|
| TAUROLIN | Austria, Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
